WHO ICTRP trial
Oral metformin treatment for unilateral upper limb lymphedema after breast…
ChiCTR2300072264 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300072264 |
|---|---|
| Public title | Oral metformin treatment for unilateral upper limb lymphedema after breast cancer multicenter prospectie randomized controlled study |
| Scientific title | Oral metformin treatment for unilateral upper limb lymphedema after breast cancer multicenter prospectie randomized controlled study |
| Primary sponsor | Affiliated Hospital of Zunyi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | lymphedema |
| Interventions | Experimental group:Take metformin plus elastic bandage compression therapy;Control group:Placebo plus elastic bandage compression therapy |
| Registration date | Jun 8, 2023 |
| Target size | Experimental group:87;Control group:87 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: